The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi

Blood Transfusion

Volumn 9, Issue 4, 2011, Pages 388-393

  Pahuja, Sangeeta ^a   Gupta, Santosh Kumar ^a   Pujani, Mukta ^a   Jain, Manjula ^a  

^a KALAWATI SARAN CHILDREN'S HOSPITAL   (India)

Author keywords

Alloimmunisation; Irregular erythrocyte antibodies; Pregnancy

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIGEN; ERYTHROCYTE ANTIBODY; RHESUS D ANTIBODY;

AGGLUTINATION TEST; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PRENATAL PERIOD; PREVALENCE; PROSPECTIVE STUDY;

ERYTHROCYTES; FEMALE; HUMANS; INDIA; ISOANTIBODIES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL CARE; PREVALENCE; PROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM;

EID: 80054881243     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2011.0050-10     Document Type: Article

References (16)

1. Koelewijn JM, Vrijkotte TG, Van der Schoot CE, et al. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008; 48: 941-52. (Pubitemid 351614905)
2. Al-Ibrahim NA, Al Saeed AH. Red blood cell alloimmunisation among Saudi pregnant women in the central province of Saudi Arabia. Kuwait Med J 2008; 40: 116-23.
3. Gottvall T, Filbey D. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden. Acta Obstet Gynecol 2008; 87: 843-8.
4. Lurie S, Eliezer E, Piper I, Woliovitch I. Is antibody screening in Rh(D)- positive pregnant women necessary? J Mater Fetal Neo-natal Med 2003; 14: 404-6. (Pubitemid 38021690)
5. Lee CK, Ma ESK, Tang M, et al. Prevalence and specificity of clinically significant red cell alloantibodies in chinese women during pregnancy- a review of cases from 1997 to 2001. Transfusion Med 2003; 13: 227-31. (Pubitemid 36950560)
6. Wu KH, Chu SL, Chang JG, et al. Hemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan. Transfusion Med 2003; 13: 311-4. (Pubitemid 37462044)
7. Chandrasekar A, Morris KG, Tubman TRJ, et al. The clinical outcome of non-RHD antibody affected pregnancies in Northern Ireland. Ulster Med J 2001; 70: 89-94. (Pubitemid 33138842)
8. Semmekrot BA, de Man AJ, Boekkooi PF, et al. Irregular blood group antibodies during pregnancy: screening is mandatory. Ned Tijdschr Geneeskd 1999; 143: 449-52.
9. De Vrijer B, Harthoorn-Lasthuizen EJ, Oosterbaan HP: The incidence of irregular antibodies in pregnancy: a prospective study in the region of the s-Hertogenbosch. Ned Tijdschr Geneeskd 1999; 143: 2523-7.
10. Howard H, Martlew V, McFadyen L, et al. Consequences for fetus and neonate of maternal red cell alloimmunisation. Arch Dis Child Fetal Neonatal Ed 1998; 78: F62-6. (Pubitemid 28241984)
11. Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in Central Sweden. Acta Obstet Gynecol Scand 1995; 74: 687-92.
12. Salola A, Sibai B, Mason JM. Irregular antibodies: an assessment of routine prenatal screening. Obstet Gynaecol 1983; 61: 25-30. (Pubitemid 13212370)
13. British Committee for standards in Haematology Guidelines for blood grouping and red cell antibody testing during pregnancy, July 2008. www.bcshguidelines.org.
14. Drugs and Cosmetics Act: The Gazette of India, Government of India. New Delhi,1989.
15. Lenkiewicz B, Zupanska B. Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N). Ginekol Pol 2003; 74: 48-54.
16. Adeniji AA, Fullar I, Dale T, Lindow SW. Should we continue screening Rhesus D positive women for the development of atypical antibodies in late pregnancy? J Matern Fetal Neonatal Med 2007; 20: 59-61. (Pubitemid 47215734)